Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;15(2):128-130.
doi: 10.1183/20734735.0018-2019.

Why ERS Early Career Members should attend the International Congress 2019 in Madrid

Niki Ubags  1   2 , Manuela Platé  3   2 , Isaac Almendros  4   5 , Sabine Bartel  6
Affiliations

Why ERS Early Career Members should attend the International Congress 2019 in Madrid

Niki Ubags et al. Breathe (Sheff). 2019 Jun.

Abstract

The #ERSCongress is the largest respiratory conference worldwide. This article points out why @ERSTalk Early Career Members can especially benefit from attending this huge event and gives upcoming fellowship deadlines. http://ow.ly/3GQ530o8Ezh.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: N. Ubags has nothing to disclose. Conflict of interest: M. Platé has nothing to disclose. Conflict of interest: I. Almendros has nothing to disclose. Conflict of interest: S. Bartel reports a grant and personal fees for advisory board membership from Bencard Allergie GmbH outside the submitted work.

References

    1. Nenna R, Petrarca L, Parisi GF, et al. . Zooming in on the ERS fellowships and the International Congress. Breathe 2018; 14: 141–144. - PMC - PubMed
    1. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR–Cas9 for genome engineering. Cell 2014; 157: 1262–1278. - PMC - PubMed
    1. Oude Blenke E, Evers MJW, Mastrobattista E, et al. . CRISPR–Cas9 gene editing: delivery aspects and therapeutic potential. J Control Release 2016; 244: 139–148. - PubMed
    1. Shen S, Sanchez ME, Blomenkamp K, et al. . Amelioration of alpha-1 antitrypsin deficiency diseases with genome editing in transgenic mice. Hum Gene Ther 2018; 29: 861–873. - PubMed
    1. Hart SL, Harrison PT. Genetic therapies for cystic fibrosis lung disease. Curr Opin Pharmacol 2017; 34: 119–124. - PubMed

LinkOut - more resources